Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Lisinopril	O
/	O
Avandia	O
/	O
Glucophage	O
/	O
Lactose	O
/	O
aspirin	O
Attending:	O
___.	O
Chief	O
Complaint:	O
right	O
flank	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
none	O
History	O
of	O
Present	O
Illness:	O
___	O
with	O
history	O
of	O
CKD,	O
HTN,	O
DM2,	O
and	O
gout	O
presents	O
3	O
days	O
of	O
R	O
flank	O
pain.	O
Per	O
report,	O
pain	O
started	O
when	O
she	O
was	O
moving	O
her	O
wheelchair-bound	O
daughter.	O
It	O
initially	O
started	O
on	O
right	O
abdomen	O
and	O
then	O
began	O
to	O
radiate	O
around	O
to	O
the	O
back.	O
Pain	O
is	O
worse	O
with	O
movement.	O
Some	O
nausea,	O
one	O
episode	O
of	O
vomiting	O
today.	O
No	O
fevers.	O
No	O
dyursia.	O
No	O
bowel	B-Faecal_incontinence
or	O
bladder	B-Urinary_incontinence
incontinence.	B-Faecal_incontinence
She	O
has	O
had	O
loss	O
of	O
appetite	O
and	O
hasn't	O
been	O
eating	O
much.	O
Patient	O
was	O
diagnosed	O
with	O
UTI	B-Urinary_tract_infection
last	O
week	O
by	O
PCP,	O
started	O
on	O
nitrofurantoin,	O
which	O
caused	O
some	O
nausea.	O
Cr	O
rose	O
on	O
follow	O
up	O
today	O
from	O
1.9	O
to	O
2.1.	O
In	O
urgent	O
care	O
today,	O
she	O
received	O
tramadol	O
for	O
pain.	O
She	O
developed	O
a	O
rapid	O
heart	O
rate	O
to	O
118	O
that	O
terminated	O
with	O
vagal	O
maneuvers.	O
Not	O
clear	O
if	O
an	O
EKG	O
of	O
this	O
was	O
obtained.	O
EKG	O
at	O
this	O
point	O
showed	O
new	O
lateral	O
TWI.	O
Of	O
note,	O
Atrius	O
CT	O
read	O
notes	O
2	O
mm	O
nonobstructing	O
stone	O
in	O
lower	O
pole	O
of	O
L	O
kidney.	O
Episode	O
of	O
SVT	O
prompted	O
transfer	O
to	O
___,	O
initial	O
VS	O
0	O
98.2	O
62	O
169/77	O
14	O
99%	O
RA.	O
EKG:	O
NSR	O
at	O
60,	O
new	O
TWI	O
in	O
V3-V6.	O
First	O
set	O
of	O
biomarkers	O
negative.	O
Ddimer	O
elevated	O
at	O
700s.	O
Discussed	O
case	O
with	O
___	O
cardiology	O
who	O
felt	O
patient	O
warranted	O
inpatient	O
evaluation	O
for	O
ACS,	O
PE	O
and	O
decision	O
made	O
to	O
admit	O
to	O
medicine	O
for	O
?stress	O
as	O
well	O
as	O
V/Q	O
scan.	O
Prior	O
to	O
transfer	O
patient	O
had	O
received	O
1L	O
NS.	O
Morphine	O
2.5mg	O
with	O
good	O
effect.	O
VS	O
prior	O
to	O
transfer:	O
5	O
98.2	O
60	O
155/64	O
14	O
100%.	O
Currently,	O
patient	O
is	O
feeling	O
almost	O
no	O
pain.	O
ROS:	O
+per	O
HPI,	O
+loose	O
stool	O
(seems	O
to	O
correspond	O
to	O
certain	O
foods,	O
including	O
dairy),	O
+cough	O
certain	O
times	O
of	O
year	O
associated	O
with	O
post-nasal	O
drip,	O
but	O
not	O
recently;	O
denies	O
fever,	O
chills,	O
night	O
sweats,	O
headache,	O
vision	O
changes,	O
rhinorrhea,	O
congestion,	O
sore	O
throat,	O
shortness	O
of	O
breath,	O
chest	O
pain,	O
abdominal	O
pain,	O
nausea,	O
vomiting,	O
constipation,	B-Constipation
BRBPR,	B-Lower_gastrointestinal_haemorrhage
melena,	B-Upper_gastrointestinal_haemorrhage
hematochezia,	B-Lower_gastrointestinal_haemorrhage
dysuria,	O
hematuria.	O
Past	O
Medical	O
History:	O
CKD	O
HTN	O
DM	O
(sees	O
Podiatry	O
at	O
___,	O
see	O
ophthalmology	O
at	O
___)	O
hyperlipidemia	O
obesity	O
History	O
of	O
palpitations	O
Cholecystectomy	O
surgery	O
in	O
___	O
Colonoscopy	O
___	O
normal:	O
repeat	O
___	O
years	O
Social	O
History:	O
___	O
Family	O
History:	O
+diabetes,	O
+colon	O
CA,	O
-heart	O
disease,	O
+ovarian	O
CA	O
Physical	O
Exam:	O
ADMISSION:	O
VS	O
-	O
98.9,	O
150/56,	O
58,	O
18,	O
100%	O
RA	O
GENERAL	O
-	O
well-appearing	O
F	O
in	O
NAD,	O
comfortable,	O
appropriate	O
HEENT	O
-	O
NC/AT,	O
PERRLA,	O
EOMI,	O
sclerae	O
anicteric,	O
MM	O
dry,	O
OP	O
clear	O
NECK	O
-	O
supple	O
LUNGS	O
-	O
CTA	O
bilat,	O
no	O
r/rh/wh,	O
good	O
air	O
movement,	O
resp	O
unlabored,	O
no	O
accessory	O
muscle	O
use	O
HEART	O
-	O
PMI	O
non-displaced,	O
RRR,	O
no	O
MRG,	O
nl	O
S1-S2	O
ABDOMEN	O
-	O
NABS,	O
soft/NT/ND,	O
no	O
masses	O
or	O
HSM,	O
no	O
rebound/guarding	O
BACK	O
-	O
no	O
CVA	O
tenderness	O
EXTREMITIES	O
-	O
WWP,	O
no	O
c/c/e	O
SKIN	O
-	O
no	O
rashes	O
or	O
lesions	O
NEURO	O
-	O
awake,	O
A&Ox3,	B-Delirium
CNs	O
II-XII	O
grossly	O
intact,	O
muscle	O
strength	O
___	O
throughout,	O
sensation	O
grossly	O
intact	O
throughout	O
.	O
DISCHARGE:	O
VS	O
-	O
98.4,	O
156/60,	O
57-64,	O
12,	O
100%	O
RA	O
GENERAL	O
-	O
well-appearing	O
F	O
in	O
NAD,	O
comfortable,	O
appropriate	O
HEENT	O
-	O
NC/AT,	O
PERRLA,	O
EOMI,	O
sclerae	O
anicteric,	O
MM	O
dry,	O
OP	O
clear	O
NECK	O
-	O
supple	O
LUNGS	O
-	O
CTA	O
bilat,	O
no	O
r/rh/wh,	O
good	O
air	O
movement,	O
resp	O
unlabored,	O
no	O
accessory	O
muscle	O
use	O
HEART	O
-	O
PMI	O
non-displaced,	O
RRR,	O
no	O
MRG,	O
nl	O
S1-S2	O
ABDOMEN	O
-	O
NABS,	O
soft/NT/ND,	O
no	O
masses	O
or	O
HSM,	O
no	O
rebound/guarding	O
BACK	O
-	O
no	O
CVA	O
tenderness	O
EXTREMITIES	O
-	O
WWP,	O
no	O
c/c/e	O
SKIN	O
-	O
no	O
rashes	O
or	O
lesions	O
NEURO	O
-	O
awake,	O
A&Ox3,	B-Delirium
CNs	O
II-XII	O
grossly	O
intact,	O
muscle	O
strength	O
___	O
throughout,	O
sensation	O
grossly	O
intact	O
throughout	O
Pertinent	O
Results:	O
LABS:	O
___	O
03:45PM	O
BLOOD	O
WBC-8.7	O
RBC-4.50	O
Hgb-13.8#	O
Hct-40.4	O
MCV-90	O
MCH-30.7	O
MCHC-34.2	O
RDW-13.0	O
Plt	O
___	O
___	O
03:45PM	O
BLOOD	O
Neuts-69.7	O
___	O
Monos-4.4	O
Eos-0.2	O
Baso-0.3	O
___	O
06:30AM	O
BLOOD	O
WBC-7.3	O
RBC-3.87*	O
Hgb-11.7*	O
Hct-35.3*	O
MCV-91	O
MCH-30.1	O
MCHC-33.1	O
RDW-12.8	O
Plt	O
___	O
___	O
03:45PM	O
BLOOD	O
Glucose-224*	O
UreaN-45*	O
Creat-2.0*	O
Na-139	O
K-7.2*	O
Cl-102	O
HCO3-22	O
AnGap-22*	O
___	O
06:20AM	O
BLOOD	O
Glucose-185*	O
UreaN-33*	O
Creat-1.6*	O
Na-144	O
K-3.6	O
Cl-108	O
HCO3-24	O
AnGap-16	O
___	O
11:30AM	O
BLOOD	O
Na-143	O
K-3.2*	O
Cl-107	O
___	O
10:57PM	O
BLOOD	O
ALT-12	O
AST-18	O
CK(CPK)-38	O
AlkPhos-89	O
TotBili-0.3	O
___	O
06:20AM	O
BLOOD	O
CK(CPK)-31	O
___	O
03:45PM	O
BLOOD	O
cTropnT-<0.01	O
___	O
10:57PM	O
BLOOD	O
CK-MB-1	O
cTropnT-<0.01	O
___	O
06:20AM	O
BLOOD	O
CK-MB-2	O
cTropnT-<0.01	O
___	O
06:20AM	O
BLOOD	O
Calcium-8.5	O
Phos-2.9	O
Mg-1.7	O
___	O
06:30AM	O
BLOOD	O
Calcium-8.5	O
Phos-2.7	O
Mg-1.7	O
___	O
03:45PM	O
BLOOD	O
D-Dimer-724*	O
___	O
03:45PM	O
BLOOD	O
TSH-1.6	O
___	O
06:10PM	O
URINE	O
Color-Straw	O
Appear-Clear	O
Sp	O
___	O
___	O
06:10PM	O
URINE	O
Blood-TR	O
Nitrite-NEG	O
Protein-100	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-6.0	O
Leuks-LG	O
___	O
06:10PM	O
URINE	O
RBC-3*	O
WBC-71*	O
Bacteri-NONE	O
Yeast-NONE	O
Epi-1	O
___	O
06:10PM	O
URINE	O
Mucous-RARE	O
.	O
MICRO:	O
Urine	O
Culture	O
___:	O
URINE	O
CULTURE	O
(Final	O
___:	O
Culture	O
workup	O
discontinued.	O
Further	O
incubation	O
showed	O
contamination	O
with	O
mixed	O
skin/genital	O
flora.	O
Clinical	O
significance	O
of	O
isolate(s)	O
uncertain.	O
Interpret	O
with	O
caution.	O
PROTEUS	O
MIRABILIS.	O
10,000-100,000	O
ORGANISMS/ML..	O
.	O
EKG	O
___:	O
Sinus	O
rhythm.	O
Voltage	O
criteria	O
for	O
left	O
ventricular	O
hypertrophy.	O
Diffuse	O
ST-T	O
wave	O
changes	O
with	O
T	O
wave	O
inversion	O
in	O
leads	O
V4-V6.	O
Prolonged	O
Q-T	O
interval.	O
Delayed	O
R	O
wave	O
transition	O
in	O
the	O
precordial	O
leads.	O
Compared	O
to	O
the	O
previous	O
tracing	O
of	O
___	O
the	O
rate	O
is	O
slower	O
and	O
the	O
T	O
wave	O
inversions	O
are	O
new.	O
Clinical	O
correlation	O
is	O
suggested.	O
___	O
___	O
.	O
CXR	O
___:	O
No	O
evidence	O
for	O
acute	O
disease	O
or	O
injury.	O
.	O
EKG	O
___:	O
Sinus	O
bradycardia.	O
Prolonged	O
Q-T	O
interval.	O
Compared	O
to	O
tracing	O
#1	O
T	O
wave	O
inversion	O
and	O
downsloping	O
ST	O
segment	O
are	O
now	O
noted	O
in	O
leads	O
V3	O
and	O
V6.	O
This	O
may	O
be	O
related	O
to	O
myocardial	O
ischemia.	O
Clinical	O
correlation	O
is	O
suggested.	O
___	O
___	O
with	O
history	O
of	O
CKD,	O
HTN,	O
DM2,	O
and	O
gout	O
presents	O
3	O
days	O
of	O
R	O
flank	O
pain	O
and	O
incidentally	O
noted	O
to	O
have	O
supraventricular	O
tachycardia.	O
#	O
Supraventricular	O
Tachycardia:	O
Patient	O
has	O
this	O
prior	O
diagnosis	O
based	O
on	O
Holter	O
monitoring	O
in	O
past	O
as	O
performed	O
by	O
her	O
PCP.	O
She	O
has	O
ongoing	O
palpitations	O
~2x/month	O
for	O
a	O
few	O
seconds	O
similar	O
to	O
what	O
she	O
had	O
in	O
outpt	O
setting	O
today	O
and	O
this	O
is	O
not	O
a	O
new	O
issue.	O
She	O
had	O
negative	O
cardiac	O
anzymes	O
but	O
we	O
did	O
not	O
pursue	O
further	O
investigation	O
for	O
PE,	O
as	O
this	O
arrhythmia	O
was	O
pre-existing	O
and	O
previously	O
worked	O
up.	O
She	O
also	O
did	O
not	O
have	O
any	O
symptoms	O
of	O
chest	O
pain	O
or	O
shortness	O
of	O
breath.	O
Cardiac	O
enzymes	O
were	O
negative	O
x	O
3.	O
Outpatient	O
stress	O
testing	O
could	O
be	O
considered	O
given	O
ECG	O
changes.	O
Atenolol	O
was	O
changed	O
to	O
metoprolol	O
given	O
borderlien	O
renal	O
function.	O
#	O
Back/Flank	O
Pain:	O
Likely	O
related	O
to	O
MSK	O
back	O
pain.	O
Pain	O
was	O
reproducible	O
on	O
exam	O
and	O
started	O
in	O
the	O
setting	O
of	O
lifting	O
gradndaughter	O
from	O
wheelchair.	O
Unlikely	O
to	O
be	O
GI	O
given	O
only	O
GI	O
sx	O
was	O
anorexia,	O
and	O
this	O
largely	O
resolved	O
during	O
the	O
admission.	O
Has	O
intermittent	O
diarrhea	O
at	O
baseline.	O
She	O
was	O
prescribed	O
lidocaine	O
patch,	O
acetaminophen,	O
and	O
tramadol	O
with	O
significant	O
improvement	O
in	O
symptoms.	O
#	O
Nephrolithiasis:	O
Asymptomatic,	O
as	O
pain	O
was	O
on	O
right	O
and	O
stone	O
was	O
on	O
left.	O
She	O
was	O
given	O
IV	O
fluids.	O
HCTZ	O
was	O
stopped	O
to	O
decrease	O
risk	O
of	O
recurrent	O
nephrolithiasis	O
in	O
future.	O
#	O
___	O
on	O
CKD:	O
Likely	O
in	O
setting	O
of	O
decreased	O
PO	O
intake.	O
Stone	O
unlikely	O
to	O
be	O
related	O
given	O
no	O
evidence	O
of	O
effects	O
on	O
kidney	O
on	O
imaging.	O
Improved	O
to	O
baseline	O
with	O
IV	O
fluids.	O
___	O
was	O
held	O
and	O
restarted	O
on	O
discharge.	O
#	O
HTN/HLD:	O
HCTZ	O
was	O
stopped.	O
___	O
was	O
held	O
and	O
restarted	O
on	O
discharge.	O
Amlodipine	O
was	O
continued.	O
We	O
switched	O
atenolol	O
to	O
metoprolol	O
given	O
renal	O
failiure.	O
#	O
DM:	O
Glargine	O
was	O
continued.	O
She	O
was	O
put	O
on	O
HISS	O
while	O
in	O
house.	O
Glipizide	O
was	O
stopped.	O
#	O
Gout:	O
Continued	O
home	O
allopurinol.	O
Transitional	O
Issues:	O
-	O
Full	O
code.	O
-	O
Potassium	O
level	O
should	O
be	O
checked	O
as	O
an	O
outpatient	O
within	O
a	O
week	O
of	O
discharge	O
given	O
the	O
stopping	O
of	O
HCTZ	O
and	O
the	O
continuation	O
___	O
and	O
potassium	O
supplement.	O
-	O
Patient	O
should	O
have	O
outpatient	O
follow	O
up	O
for	O
microscopic	O
hematuria	O
with	O
repeat	O
UA	O
to	O
ensure	O
resolved	O
after	O
passage	O
of	O
stone.	O
-	O
Pelvic	O
U/S	O
was	O
recommended	O
several	O
years	O
ago	O
by	O
OB/GYN.	O
Patient	O
agreed	O
to	O
set	O
this	O
up	O
through	O
PCP.	O
-	O
CT	O
abdomen	O
pre-admission	O
at	O
___	O
revealed	O
several	O
findings	O
that	O
require	O
outpatient	O
follow-up:	O
pulmonary	O
nodules,	O
fatty	O
infiltration	O
of	O
the	O
liver,	O
and	O
hyperdense	O
renal	O
lesion.	O
-	O
Patient	O
will	O
follow	O
up	O
with	O
GI	O
for	O
chronic	O
diarrhea	O
and	O
food	O
intolerance.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
2.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
3.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
4.	O
Potassium	O
Chloride	O
10	O
mEq	O
PO	O
DAILY	O
5.	O
Atenolol	O
50	O
mg	O
PO	O
DAILY	O
6.	O
olmesartan	O
*NF*	O
40	O
mg	O
Oral	O
daily	O
7.	O
Glargine	O
14	O
Units	O
Bedtime	O
8.	O
Hydrochlorothiazide	O
25	O
mg	O
PO	O
DAILY	O
9.	O
GlipiZIDE	O
10	O
mg	O
PO	O
BID	O
10.	O
Amlodipine	O
5	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
2.	O
Amlodipine	O
5	O
mg	O
PO	O
DAILY	O
3.	O
Glargine	O
14	O
Units	O
Bedtime	O
4.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
5.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
6.	O
Acetaminophen	O
1000	O
mg	O
PO	O
Q8H:PRN	O
pain,	O
fever	O
RX	O
*acetaminophen	O
500	O
mg	O
2	O
tablet(s)	O
by	O
mouth	O
every	O
eight	O
(8)	O
hours	O
Disp	O
#*90	O
Tablet	O
Refills:*0	O
7.	O
Lidocaine	O
5%	O
Patch	O
1	O
PTCH	O
TD	O
DAILY	O
Wear	O
for	O
12	O
hours,	O
then	O
take	O
off	O
for	O
12	O
hours	O
before	O
applying	O
next	O
patch.	O
RX	O
*lidocaine	O
5	O
%	O
(700	O
mg/patch)	O
1	O
patch	O
to	O
affected	O
area	O
daily	O
Disp	O
#*30	O
Transdermal	O
Patch	O
Refills:*0	O
8.	O
Metoprolol	O
Succinate	O
XL	O
12.5	O
mg	O
PO	O
DAILY	O
RX	O
*metoprolol	O
succinate	O
25	O
mg	O
0.5	O
(One	O
half)	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*15	O
Tablet	O
Refills:*0	O
9.	O
olmesartan	O
*NF*	O
40	O
mg	O
Oral	O
daily	O
10.	O
Potassium	O
Chloride	O
10	O
mEq	O
PO	O
DAILY	O
11.	O
TraMADOL	O
(Ultram)	O
12.5-25	O
mg	O
PO	O
Q6H:PRN	O
pain	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Muscular	O
strain	O
Nephrolithiasis	O
(kidney	O
stone)	O
Paroxysmal	O
supraventricular	O
tachycardia	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
with	O
back	O
and	O
abdominal	O
pain.	O
This	O
was	O
likely	O
due	O
to	O
muscular	O
strain.	O
Please	O
use	O
the	O
lidocaine	O
and	O
acetaminophen	O
for	O
pain,	O
and	O
please	O
continue	O
with	O
normal	O
light	O
activity,	O
but	O
avoid	O
strenuous	O
exercise	O
or	O
heavy	O
lifting	O
until	O
you're	O
feeling	O
better.	O
You	O
were	O
also	O
found	O
to	O
have	O
a	O
kidney	O
stone	O
that	O
should	O
pass	O
on	O
its	O
own.	O
However,	O
please	O
be	O
sure	O
you	O
drink	O
plenty	O
of	O
water,	O
even	O
if	O
you	O
have	O
a	O
decreased	O
appetite.	O
Please	O
follow	O
up	O
with	O
a	O
cardiologist	O
about	O
your	O
rapid	O
heart	O
rate	O
and	O
about	O
getting	O
a	O
stress	O
test.	O
Please	O
follow	O
up	O
with	O
your	O
gastroenterologist	O
about	O
your	O
diarrhea	O
and	O
food	O
intolerance.	O
Please	O
follow	O
up	O
with	O
your	O
primary	O
care	O
doctor,	O
who	O
can	O
help	O
set	O
you	O
up	O
with	O
pelvic	O
ultrasound	O
that	O
was	O
recommended	O
by	O
Dr.	O
___	O
___	O
years	O
ago.	O
Your	O
PCP	O
may	O
also	O
recommend	O
a	O
follow	O
up	O
CT	O
scan	O
or	O
studies	O
of	O
your	O
urine	O
based	O
on	O
the	O
results	O
of	O
lab	O
tests	O
and	O
CT	O
scan	O
that	O
you	O
had	O
before	O
and	O
during	O
the	O
current	O
hospitalization.	O
Attached	O
please	O
find	O
an	O
updated	O
list	O
of	O
medications.	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
here	O
at	O
___.	O
Followup	O
Instructions:	O
___	O

